397030 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Aprilbio Co. Ltd. develops long-action proteins and antibody drugs. It produces long-acting protein drugs using human Fab antibody fragments that bind specifically to serum albumin, and a Ex-12 helper phage antibody library to isolate human Fab antibodies with desired binding specificity. The firm's technology includes Serum Albumin Fab Associated technology and Human monoclonal antibody production technology. The company was founded by Sang-Hoon Cha on February 12, 2013 and is headquartered in Chuncheon-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
397030 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company